Skip to main content

Day: September 13, 2022

DNA Plc: Change in the Board of Directors

DNA PLC STOCK EXCHANGE RELEASE 13 SEPTEMBER 2022, 10:00 am EEST The Chair of DNA Plc’s Board of Directors changes. Jukka Leinonen will leave his position in the company’s Board of Directors on 13 September 2022.  DNA’s sole shareowner has decided on 13 September 2022 to choose Petter-Børre Furberg as the new Chair of the Board of Directors without holding an Extraordinary General Meeting. Jukka Leinonen retired from his post as the Head of Telenor Group’s Nordics operations (EVP Nordic Cluster) on 30 June 2022 but until now he has continued as the Chair of DNA’s Board of Directors. “I thank Jukka for his fantastic work for DNA. His contribution over the years has been remarkable, first as the leader of the company’s corporate business, then as a long-term CEO and for the past year as the Chair of the Board of Directors. During his...

Continue reading

Savosolar Plc – Managers’ Transaction, Heikki Timonen, September 2022

Savosolar Plc Company Announcement            13 September 2022 at 9.00 a.m. (CEST)Savosolar Plc – Managers’ Transaction, Heikki Timonen, September 2022 Person subject to the notification requirementName: Timonen Heikki  Position: Chief Financial Officer     Initial Notification  Reference number: 19468/5/4     IssuerName: Savosolar OyjLEI: 743700J1YZ8IEJAPDL21     Transaction detailsTransaction date: 2022-09-12Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Nature of the transaction:   EXERCISE (RIGHTS, PUT AND CALL OPTIONS) (X) Linked to stock option programmeFurther details:      Instrument: ShareISIN: FI4000512272 Volume: 31250Unit price: 0.05600 Euro Aggregated transactionsVolume: 31250Volume weighted average price: 0.05600 EuroSAVOSOLAR PLC For more...

Continue reading

Record and payment dates for Uponor Corporation’s second dividend instalment for the financial year 2021

Uponor Corporation, Stock exchange release, 13 September 2022 at 10:00 am EEST Record and payment dates for Uponor Corporation’s second dividend instalment for the financial year 2021 In the Annual General Meeting of Uponor Corporation held on 15 March 2022, it was resolved that a dividend of €0.67 per share be distributed for the financial year 2021 in two instalments. The first instalment of €0.33 per share was paid in March 2022. It was resolved in the Annual General Meeting that the second instalment will be paid in September and Uponor Corporation’s Board of Directors will decide on the payment date in its meeting in September. The Board of Directors have today decided that the dividend record date for the second instalment will be 15 September 2022 and the second instalment of €0.34 per share will be paid out on 22 September 2022. Uponor...

Continue reading

Huhtamaki invests in Emerald Technology Ventures’ sustainable packaging fund focusing on next-generation sustainable packaging solutions

HUHTAMÄKI OYJ PRESS RELEASE 13.9.2022 AT 10:00 EEST Huhtamaki invests in Emerald Technology Ventures’ sustainable packaging fund focusing on next–generation sustainable packaging solutions Huhtamaki, a global advanced manufacturer of sustainable packaging solutions, announces its investment in Emerald Technology Ventures’ sustainable packaging fund. As a limited partner, Huhtamaki will help to foster next–generation sustainable packaging solutions and tap into nascent innovation of start-ups. Huhtamaki is committed to ensuring that its innovation for sustainable packaging solutions has a net positive impact by achieving carbon neutral production and designing all its products to be recyclable, compostable or reusable by 2030. In line with this, Huhtamaki is continuously investing in innovation and seeking to develop next-generation,...

Continue reading

TAAT® Engages B&B Beyond to Lead Expansion in the U.S. Convenience Sector

B&B Beyond is owned and operated by two experienced executives from the convenience industry, including a former Chairman of the National Association of Convenience Stores (NACS). To further accelerate commercialization of TAAT®, B&B Beyond will leverage its connections to expand the brand’s presence in the United States. LAS VEGAS and VANCOUVER, British Columbia, Sept. 13, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that it has entered into a representation agreement with B&B Beyond, LLC (“B&B Beyond”). B&B Beyond is currently leveraging its relationships to present TAAT® to the management teams of national/regional convenience store chains, industry associations, and wholesale buying cooperatives....

Continue reading

Sight Sciences Announces Completion of Enrollment in SAHARA, a Randomized Clinical Trial of the TearCare® System vs Restasis®

310-patient RCT designed to evaluate the superiority of TearCare® (device) vs Restasis® (drug) in patients with chronic dry eye disease is now fully enrolled 6-Month efficacy results expected by Summer 2023MENLO PARK, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced the completion of enrollment in the SAHARA Trial, a first of its kind outcomes study designed to evaluate whether an interventional dry eye procedure with the TearCare System is superior in alleviating the signs and symptoms of dry eye disease compared to 6-months of twice daily Restasis® dry eye eyedrops (cyclosporine ophthalmic emulsion, 0.05%). Primary endpoints measured by a masked assessor...

Continue reading

Sampo plc’s share buybacks 12/09/2022

SAMPO PLC                 STOCK EXCHANGE RELEASE         13/09/2022 at 08:30 am Sampo plc’s share buybacks 12/09/2022 On Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  17,625 45.72 AQEU  59,743 45.78 CEUX  9,663 45.87 TQEX      XHELTOTAL 87,031 45.78  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based on the authorization...

Continue reading

Knowledge AI in Jordan is awarded GroJo incentives for advanced technology

Stockholm, 13 September 2022 – Anoto Group AB (publ) (“Anoto”) announces that its education subsidiary Knowledge AI Inc. (“KAIT”) has been granted GroJo award by the Ministry of Digital Economy and Entrepreneurship in Jordan and the World Bank and is provided subsidies of 50% of workers’ compensation for six months.   “This award is a recognition of our technology and outlook. Since most of our software development team is based in Jordan, this is going to help us recruit more talents as it is a prestigious award for promising companies,” says Joonhee Won, CEO of Anoto. For further information, please contact: Joonhee Won, CEO, Anoto Group AB (publ) For more information about Anoto, please visit www.anoto.com or email ir@anoto.com Anoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, SE-116 74 Stockholm This information is information...

Continue reading

ObsEva Announces Progress on Restructuring Initiatives

$7.6 million annual savings expected via reduction-in-force currently underway $6.2 million savings expected from assignment of legacy linzagolix program contracts to Kissei Pharmaceutical Co., Ltd., including $1.7 million of accounts payable assigned to date. Additional assignments are expected in the coming weeks. Company submitted plan to regain compliance with Nasdaq’s minimum stockholders’ equity rule. Additionally, Nasdaq provides notice of noncompliance with Nasdaq’s minimum bid price listing rule; Company has 180 days to regain compliance with minimum share price requirement.Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – September 13, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today announced an update on...

Continue reading

LHV Group results for August 2022

In August, AS LHV Group earned EUR 3.3 million in consolidated net profit. In this regard, AS LHV Pank earned EUR 6.6 million in net profit, with EUR 0.5 million of it originating from the servicing of clients associated with the United Kingdom branch. AS LHV Varahaldus earned EUR 96,000 in net profit; AS LHV Kindlustus generated a net loss of EUR 111,000, and LHV UK Limited generated a net loss of EUR 0.9 million. The month with otherwise strong results was affected by the EUR 2.3 million discount of the financial investment into the United Kingdom credit institution Bank North that is applying for an unrestricted banking licence. Resulting from indications of the financing round, the enterprise value has decreased. For LHV, the future holds several strategic choices, as the business side related to the company has exceeded expectations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.